Search
for
Sort by
Research 211–240 of 1000+
- Low-dose (2.5 mg/day) finasteride treatment in hirsutism
- Efficacy and safety of Finasteride (5 alpha-reductase inhibitor) monotherapy in patients with benign prostatic hyperplasia: A critical review of the literature
- Finasteride Topical Delivery Systems for Androgenetic Alopecia
- Development and ex-vivo skin permeation studies of finasteride–poly(lactic acid-<i>co</i>-glycolic acid) and minoxidil–chitosan nanoparticulate systems
- Comparison of spironolactone and spironolactone plus finasteride in the treatment of hirsutism
- Post-finasteride syndrome
- A comparative study of a gonadotropin-releasing hormone agonist and finasteride on idiopathic hirsutism.
- Therapeutic Considerations Related to Finasteride Administration in Male Androgenic Alopecia and Benign Prostatic Hyperplasia
- Post-finasteride syndrome – does it really exist?
- Finasteride in the treatment of female pattern (androgenic) alopecia: a case report and review of the literature.
- Finasteride for hair loss: a review
- Topical finasteride for male and female pattern hair loss: Is it a safe and effective alternative?
- Efficacy, tolerability, and safety of montelukast versus finasteride for the treatment of moderate acne in women: A prospective, randomized, single‐blinded, active‐controlled trial
- Male breast cancer after finasteride therapy for benign prostate hyperplasia
- Finasteride in the treatment of alopecia
- Acción de Finasteride sobre el volumen prostático en caninos con hiperplasia prostática benigna
- Hydrogel Microneedles Loaded With a Reactive Oxygen Species (ROS)‐Responsive Carbon Monoxide Donor and Finasteride for Synergistic Treatment of Androgenetic Alopecia
- EP1446 - ECE_2942 - Finasteride for treatment of androgenic male alopecia since puberty: case report
- Long-term effectiveness and safety of topical finasteride 0.25% monotherapy in male androgenetic alopecia: a 52-week real-world retrospective study
- Formulation and Evaluation of Finasteride Loaded Nanoparticles Based Topical Gel for the Management of drogenetic Alopecia
- Population-level risk of erectile dysfunction after finasteride use for androgenetic alopecia: a national cohort analysis
- Finasteride-Induced Neuropsychiatric Reactions
- P.08: Development of dissolving microneedles containing finasteride with improved permeability and bioavailability.
- Enhanced hair follicle accumulation and androgenetic alopecia treatment of finasteride by topical nanoparticles hydrogel system
- “Acute Pancreatitis Following Finasteride Toxicity: A Rare Case Report"
- Finasteride and Dutasteride in the Treatment of Androgenetic Alopecia: Risk or Benefit?
- Development and characterization of poly(lactic-co-glycolic acid) (PLGA) nanoparticles with finasteride and in vivo evaluation of their efficacy in hair growth
- Incorporation of Finasteride-Loaded Microspheres into Personalized Microneedle for Sustained Transdermal Delivery
- Comparison between dutasteride and finasteride in hair regrowth and reversal of miniaturization in male and female androgenetic alopecia: a systematic review
- Phytotherapeutic Alternatives to the Use of Finasteride and Dutasteride as 5-Alpha Reductase Inhibitors in the Treatment of Androgenetic Alopecia: A Review